Fen Xu

Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

Jinhua Yan, Bin Yao, Hongyu Kuang et al. · Hepatology · 2018 · 252 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Lack of SIRT1 (Mammalian Sirtuin 1) Activity Leads to Liver Steatosis in the SIRT1+/− Mice: A Role of Lipid Mobilization and Inflammation

Fen Xu, Zhan‐Guo Gao, Jin Zhang et al. · Endocrinology · 2010 · 225 citations · Full text

Life Sciences, Biochemistry, Inflammation +12

GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1

Fen Xu, Beisi Lin, Xiaobin Zheng et al. · Diabetologia · 2016 · 148 citations · Full text

Life Sciences, Endocrinology, Physiology +14

SIRT1 Mediates the Effect of GLP-1 Receptor Agonist Exenatide on Ameliorating Hepatic Steatosis

Fen Xu, Zhuo Li, Xiaobin Zheng et al. · Diabetes · 2014 · 113 citations

Medicine, Endocrinology, Pharmacology +13

SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis

Yunfeng Shen, Lidan Cheng, Minxuan Xu et al. · Metabolism · 2023 · 112 citations

Life Sciences, Cell Biology, Molecular Biology +17